Ledger.Open graph →
SEC Form D · filed May 13, 2021

Eikon Therapeutics, Inc

Offering
$107.8M
Sold
$102.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HAYWARD, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Adam M. Goulburn · Hayward, CADirectorRoger M. Perlmutter · Hayward, CAExec · DirectorDror M. Berman · Hayward, CADirectorLeon M. Chen · Hayward, CAExec · DirectorJames M. Tananbaum · Hayward, CADirectorJoe D. Davis · Southlake, TXExec · DirectorGeorge T. Hollan · Southlake, TXDirectorRaymond Updyke · New York, NYDirectorNicholas Stageberg · Rochester, MNExec · DirectorElaine Stageberg · Rochester, MNDirectorSimon J. Cox · Central, Hong KongDirectorJoshua Stone · McKinney, TXExec · DirectorErik Antico · Fort Collins, CODirectorTrevor Woolfe · Vancouver, British Columbia, CanadaExec · DirectorManasa Mantravadi · Indianapolis, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗